CancerLivER: Biomarker Card

Biomarker Card: Comprehensive information about a biomarker


Biomarker ID 2542
Detailed information
CancerLivER ID2542
Biomarker S100P, CD24, GPC3, DLK1, TM4SF3
Biomarker Name/Symbol (given in Publication)S100P, CD24, GPC3, DLK1, TM4SF3
BiomoleculeRNAs
SubjectHuman
Degree of ValidityPotential prognostic marker associated with HCC progression; but not validated on independent dataset
Experimental ConditionHCV-HCC v/s early HCV cirrhosis, late HCV cirrhosis, and normal liver tissues.
Cancer typeHepatocellular carcinoma
RegulationUpregulated in HCV-HCC carcinogenesis progression
Level of significance p < 0.05
SourceTissue
PMID15108252
Type of BiomarkerPrognostic
PathwayNA
Cohort22 patients undergoing liver transplantation for end-stage hepatitis C (without interferon treatment within 6 months of transplant) and 9 patients undergoing liver transplantation for alcoholic cirrhosis and 10 control liver samples (HCV-negative); (1) 5 early HCV cirrhosis ; (2) 8 late HCV-cirrhosi
SensitivityNA
SpecificityNA
AccuracyNA
AUCNA
DiseaseHCV-HCC v/s early HCV cirrhosis, late HCV cirrhosis, and normal liver tissues.
Year of Publication2004
Clinical trialNO
Clinical trial (NCT Number)NA

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top